Nature Communications (Jun 2017)

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

  • Claire Vanpouille-Box,
  • Amandine Alard,
  • Molykutty J. Aryankalayil,
  • Yasmeen Sarfraz,
  • Julie M. Diamond,
  • Robert J. Schneider,
  • Giorgio Inghirami,
  • C. Norman Coleman,
  • Silvia C. Formenti,
  • Sandra Demaria

DOI
https://doi.org/10.1038/ncomms15618
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 15

Abstract

Read online

Trex1 is an exonuclease that degrades cytosolic DNA and has been associated with modulation of interferon responses in autoimmunity and viral infections. Here, the authors show that Trex1 attenuates the immunogenicity of cancer cells treated with high radiation doses by degrading cytosolic DNA and preventing the activation of interferon response.